| # | Drug | Count |
|---|---|---|
| 0 | LORAZEPAM | 154 |
| 1 | ACETAMINOPHEN | 153 |
| 2 | ADALIMUMAB | 151 |
| 3 | DICLOFENAC SODIUM | 150 |
| 4 | DICLOFENAC | 149 |
| 5 | SECUKINUMAB | 148 |
| 6 | LEFLUNOMIDE | 146 |
| 7 | ACETAMINOPHEN 500MG | 145 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 145 |
| 9 | DICLOFENAC SODIUM 1% | 145 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAFFEINE CITRATE | 93 | 0.0398 |
| 1 | RITUXIMAB AND HYALURONIDASE | 13 | 0.0287 |
| 2 | FLUOROMETHOLONE | 75 | 0.0230 |
| 3 | HYDROCORTISONE BUTYRATE | 40 | 0.0202 |
| 4 | APREPITANT | 121 | 0.0161 |
| 5 | DICLOFENAC POTASSIUM TABLETS | 135 | 0.0156 |
| 6 | TRIPROLIDINE HYDROCHLORIDE | 3 | 0.0154 |
| 7 | PIROXICAM | 97 | 0.0152 |
| 8 | HYDROCORTISONE SODIUM SUCCINATE | 52 | 0.0130 |
| 9 | DICLOFENAC POTASSIUM | 135 | 0.0122 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 176 |
| 1 | Benzodiazepine [EPC] | 155 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 154 |
| 3 | Corticosteroid [EPC] | 152 |
| 4 | Vitamin C [EPC] | 150 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 149 |
| 6 | Aminosalicylate [EPC] | 147 |
| 7 | Antirheumatic Agent [EPC] | 146 |
| 8 | Tetracycline-class Drug [EPC] | 143 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 141 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 105 | 0.0567 |
| 1 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 50 | 0.0057 |
| 3 | Provitamin D2 Compound [EPC] | 132 | 0.0044 |
| 4 | Methylxanthine [EPC] | 139 | 0.0024 |
| 5 | Macrolide Antimicrobial [EPC] | 123 | 0.0023 |
| 6 | Tetracycline-class Drug [EPC] | 143 | 0.0020 |
| 7 | Central Nervous System Stimulant [EPC] | 139 | 0.0016 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 124 | 0.0015 |
| 9 | Aminosalicylate [EPC] | 147 | 0.0015 |